Print Version
OCTOBER 10, 2005 -
Friday, November 11, 2005, the Preeclampsia Foundation is hosting a CME (Continuing Medical Education) seminar from 2:30 - 5:30 p.m. at the DoubleTree Hotel in Minneapolis, Minnesota, to provide health care professionals the latest research and clinical practices on preeclampsia, a pregnancy disorder affecting 200,000 women each year in the United States. The Continuing Medical Education seminar will include the latest information on preeclampsia diagnosis, treatments and future health implications. To register for the CME seminar or for more information, visit www.preeclampsia.org, or contact Jaime Nolan at (952) 252-3573.
Speakers at the seminar include: Dr. Thomas Easterling, Associate Professor at the University of Washington School of Medicine, and Acting Director of the Maternal-Fetal Medicine Division; Dr. Edmund Funai, Associate Professor at Yale University School of Medicine, and Co-Chief Division Maternal-Fetal Medicine; and Dr. Tanya Melnik, Associate Professor at the University of Minnesota Department of Medicine.
The CME seminar will cover the current criteria to diagnosis and the latest research in the pathogenesis and management of hypertensive disorders of pregnancy. Research and data regarding the causes of long term mortality in preeclampsia survivors will be reviewed. Finally, recent research linking hypertension in pregnancy and a woman's risk of cardiovascular disease will be shared. This CME seminar is accredited by the University of Minnesota for three category 2.75 credits.
The target audience includes: OB/GYN, Maternal-Fetal Medicine, Family Medicine, Internal Medicine providers, as well as certified Nurse Midwives, Nurse Practitioners and experienced labor and delivery nurses.
"The Deborah E. Powell Center is pleased to work with Preeclampsia Foundation to bring this event. We feel this collaboration bringing together a variety of professionals to learn more about preeclampsia can make a difference in the lives of pregnant women and their unborn babies," says Becky Gams, Clinical Coordinator for the Deborah E. Powell Center.
Preeclampsia is a disorder that occurs only during the second half of pregnancy or postpartum and affects both the mother and the unborn baby, sometimes fatally. It is characterized by high blood pressure, swelling, sudden weight gain, headaches, changes in vision and presence of protein in the urine.
The Preeclampsia Foundation is a 501(c)(3) nonprofit organization established in 2000. Its purpose is to reduce maternal and infant illness and death due to preeclampsia by supporting innovative research, raising public awareness, and helping women access safe reproductive technology, support and care. More information is available at www.preeclampsia.org or (800) 665-9341.
###